Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Yau

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
JAMA Oncology|August 21, 2015
Rethinking the Standard for Ductal Carcinoma In Situ TreatmentLaura Esserman, Christina Yau
JAMA Oncology|March 12, 2016
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ-ReplyLaura Esserman, Christina Yau
Nature Reviews. Cancer|October 25, 2008
Ageing, oxidative stress and cancer: paradigms in parallaxChristopher C Benz, Christina Yau
Breast Cancer Research : BCR|July 18, 2008
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancersChristina Yau, Christopher C Benz
Breast Cancer Research and Treatment|July 5, 2022
Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancerNeelima Vidula, Christina Yau, Hope Rugo
Breast Cancer (Tokyo, Japan)|September 7, 2023
Glutaminase (GLS1) gene expression in primary breast cancerNeelima Vidula, Christina Yau, Hope S Rugo
Breast Cancer Research and Treatment|April 29, 2021
Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancerNeelima Vidula, Christina Yau, Hope S Rugo
JAMA Surgery|February 22, 2023
Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy-ReplyRita A Mukhtar, Christina Yau, Laura J Esserman
NPJ Breast Cancer|December 17, 2019
Androgen receptor gene expression in primary breast cancerNeelima Vidula, Christina Yau, Denise Wolf, et al.
The Lancet. Oncology|March 3, 2022
Survivorship after neoadjuvant chemotherapy - Authors' replyChristina Yau, Marie Osdoit, Laura J Esserman, et al.
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
JAMA Oncology|August 21, 2015
Rethinking the Standard for Ductal Carcinoma In Situ TreatmentLaura Esserman, Christina Yau
JAMA Oncology|March 12, 2016
Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ-ReplyLaura Esserman, Christina Yau
Nature Reviews. Cancer|October 25, 2008
Ageing, oxidative stress and cancer: paradigms in parallaxChristopher C Benz, Christina Yau
Breast Cancer Research : BCR|July 18, 2008
Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancersChristina Yau, Christopher C Benz
Breast Cancer Research and Treatment|July 5, 2022
Trophoblast Cell Surface Antigen 2 gene (TACSTD2) expression in primary breast cancerNeelima Vidula, Christina Yau, Hope Rugo
Breast Cancer (Tokyo, Japan)|September 7, 2023
Glutaminase (GLS1) gene expression in primary breast cancerNeelima Vidula, Christina Yau, Hope S Rugo
Breast Cancer Research and Treatment|April 29, 2021
Programmed cell death 1 (PD-1) receptor and programmed death ligand 1 (PD-L1) gene expression in primary breast cancerNeelima Vidula, Christina Yau, Hope S Rugo
JAMA Surgery|February 22, 2023
Prognostic Significance of Residual Ductal Carcinoma In Situ After Complete Response of Invasive Breast Cancer to Neoadjuvant Therapy-ReplyRita A Mukhtar, Christina Yau, Laura J Esserman
NPJ Breast Cancer|December 17, 2019
Androgen receptor gene expression in primary breast cancerNeelima Vidula, Christina Yau, Denise Wolf, et al.
The Lancet. Oncology|March 3, 2022
Survivorship after neoadjuvant chemotherapy - Authors' replyChristina Yau, Marie Osdoit, Laura J Esserman, et al.
Pageof 15